Business Spend management for Today and Tomorrow: Creating a Scalable Foundation for Growth

Register Free: https://www.pharmexec.com/pe_w/today-and-tomorrow

Event Overview:

Business Spend Management for Today and Tomorrow: Creating a Scalable Foundation for Growth
Hosted by Sikich and Coupa, join this webinar to learn how Werewolf Therapeutics – an innovative biopharmaceutical company – successfully transformed their spend management processes by driving efficiencies, increasing savings, and implementing efficient, compliant systems on a scalable foundation for growth.
2022 holds many challenges for business, especially life sciences companies facing periods of expansion, both today and in the long term. Michael Woodbury of Werewolf Therapeutics will share his firsthand insights, lessons learned, and key decision points that allowed Werewolf to build mission-aligned, transformative value by increasing spend visibility, implementing strong controls, and upgrading their business systems and processes to support their expected growth.
Key Learning Objectives:

• Streamline processes to accomplish more with fewer resources
• Implement sustainable, integrated systems that increase awareness of spending and reduce risk across the organization
• Align stakeholders on making a change that supports your business today and in the future

Who Should Attend:

• Finance and procurement professionals/leaders at life sciences companies
  

Michael Manna
Regional Vice President
Coupa

Michael Manna is a Regional Vice President at Coupa who supports growing life sciences organizations.
Michael has been with Coupa for over 2½ years and has a background in helping business and IT leaders improve spend visibility and control, while driving efficiencies, compliance, and savings across their organizations. Prior to Coupa, Michael worked at Oracle for 6½ years, where he helped companies improve processes around ERP, EPM, SCM, and HCM.
Michael Woodbury, CPACorporate ControllerWerewolf Therapeutics


Michael Woodbury, CPA
Corporate Controller
Werewolf Therapeutics

Michael is employed full-time as the Corporate Controller at Werewolf Therapeutics, a public Cambridge biotechnology company specializing in immuno-oncology, reporting to the Chief Financial Officer. He holds a Certified Public Accountant license in the state of Massachusetts.

Michael was previously employed by Amylyx Pharmaceuticals from July 2020 through March 2021, and Jounce Therapeutics from November 2015 through July 2020. At Jounce, Michael gained tremendous experience in a high-growth, hands-on environment that transitioned to being a public company, including extensive systems implementation experience. Before Jounce, he was employed by EY from October 2014 through November 2015 in its commercial assurance practice. Also, in 2013, Michael participated in EY's 2013 Global Student Exchange program in Tel Aviv, Israel, as part of a highly competitive internship program with over 500 applicants and only 40 accepted participants.

Jim Ingram
Account Executive
Sikich

Jim is a seasoned account executive who specializes in helping CROs and life sciences companies leverage technology to improve business outcomes. He’s passionate about helping clients select, implement, and support business productivity tools such as NetSuite and Coupa.

Register Free: https://www.pharmexec.com/pe_w/today-and-tomorrow